Published May 21, 2004 | Version v1
Report Restricted

Boron Neutron Capture Therapy of Brain Tumors: Targeting Strategies and Therapeutic Models. Final Progress Report for February 1, 2003 - July 31, 2003

Creators

Description

The overall goal of this project was to evaluate either boronated EGF or anti-EGFR monoclonal antibodies (MoAbs) as delivery agents for boron neutron capture therapy (BNCT)

Availability note (English)

Available from INIS in electronic form; Also available from OSTI as DE00825198; PURL: https://www.osti.gov/servlets/purl/825198-GYyb4j/native/

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Additional details

Identifiers

URL
https://www.osti.gov/servlets/purl/825198-GYyb4j/native/;

Publishing Information

Imprint Pagination
4 p.
Report number
INIS-US--0280

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
35078791
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Progress Report
Descriptors DEI
BORON; BRAIN; MONOCLONAL ANTIBODIES; NEOPLASMS; NEUTRON CAPTURE THERAPY; PROGRESS REPORT
Descriptors DEC
ANTIBODIES; BODY; CENTRAL NERVOUS SYSTEM; DISEASES; DOCUMENT TYPES; ELEMENTS; MEDICINE; NERVOUS SYSTEM; NEUTRON THERAPY; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; SEMIMETALS; THERAPY

Optional Information

Contract/Grant/Project number
FG02-98ER62595
Funding organization
USDOE Office of Energy Research (ER) (United States)